Saltar al contenido
Merck

Heterocyclic bibenzimidazole derivatives as topoisomerase I inhibitors.

Bioorganic & medicinal chemistry letters (2000-04-27)
S Jin, J S Kim, S P Sim, A Liu, D S Pilch, L F Liu, E J LaVoie
RESUMEN

A series of 2'-heterocyclic derivatives of 5-phenyl-2,5'-1H-bibenzimidazoles were evaluated for topoisomerase I poisoning activity and cytotoxicity. Topo I poisoning activity was associated with 2'-derivatives that possessed a hydrogen atom capable of hydrogen bond formation, suggesting that the interatomic distances between such hydrogen atoms and the heteroatoms on the adjacent benzimidazole influence activity.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Indole-5-carboxaldehyde, 98%